Table 1.
Characteristics of the Patients for Endpoint 1
| Characteristics | IPR | CTR | P Value |
|---|---|---|---|
| n = 24 | n = 26 | ||
| Age, years | 59.0 (46.8‐64.3) | 50.0 (48.0‐68.8) | 0.82 |
| Male, n (%) | 15 (62.5) | 14 (53.8) | 0.54 |
| BMI, kg/m2 | 29.9 (27.2‐32.3) | 28.8 (25.7‐32.9) | 0.85 |
| Hypertension, n (%) | 9 (37.5) | 7 (26.9) | 0.42 |
| Dyslipidemia, n (%) | 13 (54.2) | 19 (73.1) | 0.16 |
| Platelet count, ×103/µL | 19.6 (16.2‐23.5) | 22.0 (18.6‐27.1) | 0.29 |
| AST, U/L | 43.5 (35.3‐57.0) | 41.5 (33.0‐75.5) | 0.17 |
| ALT, U/L | 57.0 (43.8‐70.3) | 52.0 (38.3‐99.0) | 0.60 |
| GGT, U/L | 69.0 (39.5‐112.5) | 55.5 (36.3‐93.0) | 0.70 |
| Fasting glucose, mg/dL | 115 (102‐133) | 123(113‐142) | 0.10 |
| HbA1c, % | 6.5 (6.1‐7.1) | 6.8 (6.3‐7.0) | 0.27 |
| Ferritin, ng/mL | 256 (149‐311) | 177 (100‐346) | 0.57 |
| Visceral fat area, cm2 | 181(162‐234) | 176 (141.5‐226) | 0.70 |
| Subcutaneous fat area, cm2 | 238 (187‐289) | 237 (169‐311) | 0.78 |
Continuous valuables are shown as median (lower and upper quartile). The complete list of characteristics of the patients for endpoint 2 is available in Supporting Table S1. P values were calculated using the chi‐square test or Welch’s t‐test.